Unfortunately, TP53 mutations in exons 5, 7, 8, and 9 did not produce more favorable prognosis than other sites in the advanced NSCLC patients carrying ERBB2 mutation. The gene discussed is ERBB2; the disease is non-small cell lung carcinoma.